Original Research

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Lakhotia B, Mahon R, Gutzwiller FS, Danyliv A, Nikolaev I, Thokala P

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:787-797

Published Date: 16 April 2020